Wesana Health Announces Closing Of PsyTech Acquisition

Wesana Health Holdings Inc., an emerging data driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and performance, including through the advancement of psychedelic medicines, announced the closing on September 8, 2021 of its acquisition of Psychedelitech Inc., also known as PsyTech. As this transaction closes, Wesana is also pleased to announce that it has started the process of applying to list its subordinate voting shares on a US national stock exchange.

The acquisition of PsyTech as a wholly owned subsidiary of Wesana will add three major components that will expand and . . .